drugset / Trial / NCT01485146
A Multiple Ascending Dose Study of ETC-1002 in Healthy Subjects
RandomizedSingle-groupDouble-blindTreatment
Summary
This Phase 1, double-blind (sponsor open), placebo controlled study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of ETC-1002 in healthy subjects.
Timeline
- Start
- 2011-10-25
- Primary completion
- 2012-01-25
- Completion
- 2012-01-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bempedoic acid | Small molecule | — | — |
Indications
No indication recorded.